Collins On Board With Anti-Smoking Interests
WASHINGTON, D.C. -- Senator Susan Collins is cosponsoring an anti-smoking bill that will give the Food and Drug Administration (FDA) the authority to regulate the sale, marketing, and advertising of tobacco products. The legislation would also allow the F
"Many people may not know that no federal agency has the authority to require tobacco companies to list the ingredients that are in their products or to inspect manufacturing operations. Our legislation arms the FDA with the authority to do both," said Senator Collins. "Our legislation also aims to protect children from the dangers of tobacco. It will provide a powerful tool to help add to the success that Maine has had in recent years in reducing the number of young smokers."
The Family Smoking Prevention and Tobacco Control Act would give consumers more information about what's in tobacco products, such as trace amounts of arsenic, formaldehyde, and ammonia. Specifically, the bill would provide the FDA with the ability to publish the ingredients of tobacco products and revise the health warnings on both cigarette and smokeless tobacco products. All tobacco products entering the market would be subjected to an FDA approval process.
"For the first time ever, the FDA would be able to review the health risks associated with tobacco products, regulate tobacco products, and have the full legal authority to do the job effectively," said Senator Collins.
The legislation would require tobacco manufacturers to disclose a listing of all ingredients, substances, and compounds added to the tobacco, paper, or filter. It would require a description of the content, delivery, and form of nicotine in each tobacco product. It would also require information on the health, behavioral, or physiologic effects of the tobacco products.
The bill has the support of Campaign for Tobacco Free Kids, Philip Morris, the American Heart Association, American Lung Association, and American Cancer Association.